Financing ·
Prenetics Global Limited announced the closing of a $1 billion growth financing arrangement with General Catalyst's…
PREPrenetics Global Ltd
Prenetics Global Limited announced the closing of a $1 billion growth financing arrangement with General Catalyst's Customer Value Fund on July 14, 2026. The funding supports sales and marketing expansion for its IM8 business through a Customer Investment Agreement dated July 13, 2026. Investors will fund up to 70% of monthly growth spend until August 11, 2028, subject to repayment from customer collections capped at a 30% internal rate of return or a multiple between 1.035x and 1.170x. Prenetics Limited and IM8 Limited provided unconditional guarantees for the obligations. The company operates in the direct-to-consumer health sciences industry.